Hypertrophic cardiomyopathy: Difference between revisions
No edit summary |
No edit summary |
||
| Line 25: | Line 25: | ||
==Pathophysiology== | ==Pathophysiology== | ||
[[ | [[Hypertrophic_cardiomyopathy_histopathology|Histopathologic Abnormalities]] | [[Hypertrophic cardiomyopathy pathophysiology#Anatomic Abnormalities|Anatomic Abnormalities]] | [[Hypertrophic cardiomyopathy pathophysiology#Functional Abnormalities|Functional Abnormalities]] | ||
==[[Hypertrophic cardiomyopathy epidemiology and genetics|Epidemiology and genetics]]== | ==[[Hypertrophic cardiomyopathy epidemiology and genetics|Epidemiology and genetics]]== | ||
Revision as of 23:05, 12 August 2011
For patient information click here
| Hypertrophic cardiomyopathy | |
 | |
|---|---|
| Hypertrophic cardiomyopathy. Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology | |
| ICD-10 | I42.1-I42.2 |
| ICD-9 | 425.4 |
| DiseasesDB | 6373 |
| MeSH | D002312 |
|
Hypertrophic Cardiomyopathy Microchapters |
|
Differentiating Hypertrophic Cardiomyopathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hypertrophic cardiomyopathy On the Web |
|
Directions to Hospitals Treating Hypertrophic cardiomyopathy |
|
Risk calculators and risk factors for Hypertrophic cardiomyopathy |
Editors-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and Related Terms: Hypertrophic cardiomyopathy or HCM, Asymmetric septal hypertrophy or ASH, Hypertrophic obstructive cardiomyopathy, HOCM, Idiopathic hypertrophic subaortic stenosis or IHSS, familial isolated hypertrophic obstructive cardiomyopathy, familial isolated hypertrophic subaortic stenosis, familial or idiopathic hypertrophic subaortic stenosis, familial or idiopathic hypertrophic obstructive cardiomyopathy, primitive hypertrophic obstructive cardiomyopathy, primitive hypertrophic subaortic stenosis, muscular subaortic stenosis, apical hypertrophic cardiomyopathy, which is also known as nonobstructive hypertrophic cardiomyopathy and Japanese variant hypertrophic cardiomyopathy or the Yamaguchi variant (since the first cases described were all in individuals of Japanese descent).
Overview
Pathophysiology
Histopathologic Abnormalities | Anatomic Abnormalities | Functional Abnormalities
Epidemiology and genetics
Natural History, Prognosis and Sudden Cardiac Death Risk
Diagnosis
Differential Diagnosis | Symptoms | Physical examination | Screening | Electrocardiogram | Echocardiography | Cardiac MRI | Cardiac CT | Positron Emission Tomography | Cardiac Catheterization | Electrophysiologic study | Pathological Findings
Treatment
Medical treatment | Interventional Cardiology and Device Based Therapy | Surgical treatment
Special clinical scenarios
Hypotension/Cardiovascular collapse | Pregnancy
External links
- Hypertrophic Cardiomyopathy Association
- Cardiomyopathy Association
- Hypertrophic Cardiomyopathy Research Foundation